AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - AstraZeneca PLC - AZN: FY16 and Q4 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
02/02/2017 07:06Announcement
REG - AstraZeneca PLC - AZN: FY16 and Q4 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
02/02/2017 07:06Announcement
REG - AstraZeneca PLC - AZN: FY16 and Q4 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
02/02/2017 07:06Announcement
REG - AstraZeneca PLC - AZN: FY16 and Q4 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
02/02/2017 07:06Announcement
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
01/02/2017 16:00Announcement
REG - AstraZeneca PLC - SYMBICORT GRANTED PAEDIATRIC EXCLUSIVITY IN THE US <Origin Href="QuoteRef">AZN.L</Origin>
26/01/2017 10:05Announcement
REG - AstraZeneca PLC - AZ 1st-line lung cancer immuno-oncology programme <Origin Href="QuoteRef">AZN.L</Origin>
17/01/2017 07:06Announcement
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
03/01/2017 16:00Announcement
REG - AstraZeneca PLC - AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS <Origin Href="QuoteRef">AZN.L</Origin>
23/12/2016 07:00Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
16/12/2016 13:00Announcement
REG - AstraZeneca PLC - FDA accepts durvalumab for BLA in bladder cancer <Origin Href="QuoteRef">AZN.L</Origin>
09/12/2016 15:10Announcement
REG - AstraZeneca PLC - Tagrisso data shows superiority over chemotherapy <Origin Href="QuoteRef">AZN.L</Origin>
06/12/2016 09:35Announcement
REG - AstraZeneca PLC - AZ completes agreement for Rhinocort Aqua rights <Origin Href="QuoteRef">AZN.L</Origin>
05/12/2016 07:05Announcement
REG - AstraZeneca PLC - Block listing Interim Review <Origin Href="QuoteRef">AZN.L</Origin>
01/12/2016 16:00Announcement
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
01/12/2016 15:05Announcement
REG - AstraZeneca PLC - AZ head and neck cancer trials resume enrolment <Origin Href="QuoteRef">AZN.L</Origin>
22/11/2016 07:07Announcement
REG - AstraZeneca PLC - AZ out-licensing deal with Allergan completed <Origin Href="QuoteRef">AZN.L</Origin>
17/11/2016 07:05Announcement
REG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
10/11/2016 07:10Announcement
REG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
10/11/2016 07:10Announcement
REG - AstraZeneca PLC - Year-To-Date and Q3 2016 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
10/11/2016 07:10Announcement